Tart cherry juice probably won’t meaningfully lower your cholesterol. While a few individual studies have found modest reductions in LDL cholesterol after weeks of daily consumption, the strongest available evidence, a meta-analysis pooling ten randomized controlled trials, found no significant effect on total cholesterol, LDL, HDL, or triglycerides. The picture is more nuanced than a simple yes or no, though, and there are a few findings worth understanding before you stock up.
What the Best Evidence Actually Shows
A systematic review and meta-analysis of ten randomized controlled trials looked at tart cherry juice’s effects on a range of metabolic markers. When researchers pooled the data, tart cherry juice did not significantly change total cholesterol, LDL cholesterol, HDL cholesterol, or triglycerides. The one clear finding was a small but statistically significant reduction in fasting blood sugar.
That said, subgroup analyses within the same review did turn up some significant effects on LDL, HDL, total cholesterol, and triglycerides in specific populations. This means the juice may help certain groups of people, likely older adults or those with higher baseline risk factors, but the overall signal across all participants was too weak and inconsistent to draw a confident conclusion.
A 2024 proof-of-concept study testing powdered tart cherry supplementation reinforced this. Researchers found no effect on blood lipids after either a single dose or one week of daily use. The study authors noted that their results aligned with the meta-analysis: tart cherry consumption does not appear to affect total cholesterol, LDL, HDL, or triglycerides in most people.
Where the Positive Results Come From
The most cited positive finding comes from a study in older adults who drank tart cherry juice daily for 12 weeks. Researchers reported lower LDL cholesterol and systolic blood pressure compared to a control group. They also found that oxidized LDL, a particularly harmful form of cholesterol that contributes to artery plaque buildup, dropped by about 11% from baseline. A marker of inflammation called C-reactive protein fell by roughly 25%.
These results are genuinely interesting, but they come from a single study with a specific population (older adults) over a relatively long period. When those findings are combined with results from other trials involving different ages and shorter durations, the cholesterol-lowering effect washes out. That’s the core tension in this research: some studies see a benefit, but the overall body of evidence doesn’t support it reliably.
How Tart Cherry Might Affect Heart Health
Tart cherries, especially the Montmorency variety used in most research, are rich in anthocyanins. These are the pigments that give the fruit its deep red color, and they function as potent antioxidants in the body. The primary anthocyanins in tart cherries have anti-inflammatory activity that, in lab studies, has been compared to ibuprofen and naproxen in terms of how they block inflammatory enzymes.
The theory behind any cholesterol benefit centers on inflammation and oxidative stress rather than a direct effect on cholesterol production. Unlike statins, which block the liver’s ability to make cholesterol, tart cherry compounds appear to reduce inflammation and protect LDL particles from becoming oxidized. Oxidized LDL is what actually embeds in artery walls and drives plaque formation, so even without changing your LDL number on a blood test, reducing oxidation could still offer some cardiovascular protection. This is a plausible mechanism, but the clinical evidence in humans hasn’t consistently backed it up yet.
Sugar Content and Practical Trade-offs
If you’re considering tart cherry juice for heart health, the sugar content matters. Unsweetened tart cherry juice contains roughly 13 grams of sugar per 150 milliliters (about 5 ounces). That’s less than most fruit juices ounce for ounce, and tart cherry juice has a glycemic index of about 45, which is considered low. For comparison, a typical sports drink has a glycemic index around 89.
Still, if you’re drinking 8 ounces twice a day, as some studies use, the sugar adds up. For someone managing cholesterol alongside blood sugar or weight concerns, this is worth considering. Concentrated tart cherry supplements in capsule or powder form offer the anthocyanins without the sugar, though these have been studied less.
Using Tart Cherry Juice Alongside Statins
There’s no documented harmful interaction between tart cherry juice and statin medications. In fact, one lab study found that tart cherry anthocyanins and atorvastatin (a common statin) worked synergistically, meaning together they reduced inflammatory signaling from fat cells more effectively than either one alone. The researchers suggested that combining dietary anthocyanins with statins could potentially allow for lower drug doses and fewer side effects, though this hasn’t been tested in human clinical trials.
If you’re already taking a statin and want to add tart cherry juice to your routine, there’s no known reason you can’t. Just don’t expect it to replace your medication. The cholesterol-lowering power of statins is well established and far exceeds anything tart cherry juice has demonstrated.
What Tart Cherry Juice Is Good For
Even though the cholesterol evidence is weak, tart cherry juice does have legitimate health benefits supported by stronger data. The most consistent finding across studies is reduced inflammation and oxidative stress. It also reliably lowers fasting blood sugar by a small but significant amount, particularly in people over 40 and those with a BMI over 30. It’s widely studied for exercise recovery and sleep quality as well, with more consistent positive results in those areas than for cholesterol.
If you enjoy tart cherry juice, it’s a reasonable addition to a heart-healthy diet. It contains beneficial plant compounds, has anti-inflammatory properties, and won’t hurt your lipid profile. But if your primary goal is lowering cholesterol, the evidence says you’ll need to look elsewhere for a meaningful effect.

